Rikoon Group LLC Invests $229,000 in UnitedHealth Group Inc (UNH) Stock

Rikoon Group LLC acquired a new stake in UnitedHealth Group Inc (NYSE:UNH) in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 1,057 shares of the healthcare conglomerate’s stock, valued at approximately $229,000.

A number of other large investors have also made changes to their positions in UNH. Aevitas Wealth Management Inc. bought a new position in shares of UnitedHealth Group during the 4th quarter worth $102,000. Bamco Inc. NY bought a new position in shares of UnitedHealth Group during the 1st quarter worth $117,000. Pathstone Family Office LLC bought a new position in shares of UnitedHealth Group during the 4th quarter worth $129,000. Trustcore Financial Services LLC bought a new position in shares of UnitedHealth Group during the 4th quarter worth $133,000. Finally, Bruderman Asset Management LLC bought a new position in shares of UnitedHealth Group during the 1st quarter worth $134,000. Hedge funds and other institutional investors own 84.94% of the company’s stock.

NYSE:UNH opened at $246.98 on Wednesday. UnitedHealth Group Inc has a twelve month low of $183.86 and a twelve month high of $256.73. The stock has a market capitalization of $235.77 billion, a price-to-earnings ratio of 24.53, a price-to-earnings-growth ratio of 1.41 and a beta of 0.77. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.71 and a current ratio of 0.71.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, April 17th. The healthcare conglomerate reported $3.04 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.13. UnitedHealth Group had a return on equity of 22.06% and a net margin of 5.41%. The firm had revenue of $55.19 billion for the quarter, compared to analysts’ expectations of $54.90 billion. During the same quarter last year, the firm posted $2.37 EPS. The company’s revenue was up 13.3% compared to the same quarter last year. research analysts expect that UnitedHealth Group Inc will post 12.62 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 26th. Stockholders of record on Monday, June 18th were given a dividend of $0.90 per share. The ex-dividend date of this dividend was Friday, June 15th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $0.75. This represents a $3.60 annualized dividend and a dividend yield of 1.46%. UnitedHealth Group’s dividend payout ratio is 35.75%.

UnitedHealth Group declared that its Board of Directors has approved a stock repurchase plan on Wednesday, June 6th that permits the company to buyback 100,000,000 outstanding shares. This buyback authorization permits the healthcare conglomerate to repurchase shares of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s management believes its shares are undervalued.

Several research firms have recently weighed in on UNH. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday, March 28th. Credit Suisse Group reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Friday, March 9th. ValuEngine upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Wednesday, May 2nd. JPMorgan Chase & Co. increased their price objective on UnitedHealth Group to $266.00 and gave the stock an “overweight” rating in a report on Wednesday, April 18th. Finally, Oppenheimer increased their price objective on UnitedHealth Group from $260.00 to $276.00 and gave the stock an “outperform” rating in a report on Wednesday, April 18th. One research analyst has rated the stock with a hold rating and twenty-six have given a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $263.00.

In other news, Director Kenneth Irwin Shine sold 202 shares of the stock in a transaction dated Thursday, April 19th. The stock was sold at an average price of $237.42, for a total transaction of $47,958.84. Following the transaction, the director now directly owns 28,948 shares in the company, valued at approximately $6,872,834.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Richard T. Burke sold 15,000 shares of the stock in a transaction dated Monday, April 23rd. The shares were sold at an average price of $234.20, for a total value of $3,513,000.00. Following the transaction, the director now owns 1,761,533 shares in the company, valued at $412,551,028.60. The disclosure for this sale can be found here. Insiders have sold a total of 49,854 shares of company stock worth $12,295,675 over the last quarter. Corporate insiders own 0.87% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply